国际医药卫生导报2024,Vol.30Issue(5) :732-735.DOI:10.3760/cma.j.issn.1007-1245.2024.05.005

PD-L1与肿瘤相关巨噬细胞在乳腺癌中的研究进展

Research progress of PD-L1 and tumor-associated macrophages in breast cancer

陈妙玲 韩玉贞
国际医药卫生导报2024,Vol.30Issue(5) :732-735.DOI:10.3760/cma.j.issn.1007-1245.2024.05.005

PD-L1与肿瘤相关巨噬细胞在乳腺癌中的研究进展

Research progress of PD-L1 and tumor-associated macrophages in breast cancer

陈妙玲 1韩玉贞1
扫码查看

作者信息

  • 1. 滨州医学院附属医院病理科,滨州 256600
  • 折叠

摘要

肿瘤微环境中存在着许多发挥免疫抑制作用的成分,其中程序性细胞死亡配体-1(PD-L1)与肿瘤相关巨噬细胞(TAMs)关系密切,其在乳腺癌的发生发展中发挥重要作用.本文对PD-L1和TAMs在乳腺癌发生发展中的意义和两者之间可能存在的相互作用机制,以及靶向TAMs在抗程序性细胞死亡受体-1(PD-1)/PD-L1治疗乳腺癌中的影响进行综述.

Abstract

Tumor microenvironment has many components that play an immunosuppressive role;among which,programmed cell death-ligand 1(PD-L1)is closely related to tumor-associated macrophages(TAMs),and plays a vital role in the occurrence and development of breast cancer.This article reviews the significance of PD-L1 and TAMs in the occurrence and development of breast cancer and the possible interaction mechanism between them,as well as the effects of anti-programmed cell death protein-1(PD-1)/PD-L1 combined with targeting TAMs in the treatment of breast cancer.

关键词

乳腺癌/PD-L1/肿瘤相关巨噬细胞/免疫抑制/肿瘤微环境/进展

Key words

Breast neoplasm/PD-L1/Tumor-associated macrophages/Immunosuppression/Tumor microenvironment/Progress

引用本文复制引用

基金项目

山东省自然科学基金(ZR2010HM096)

出版年

2024
国际医药卫生导报
中华医学会,国际医药卫生导报社

国际医药卫生导报

影响因子:0.781
ISSN:1007-1245
参考文献量33
段落导航相关论文